(02) 6620 1800 [email protected]

More than 65% of people aged over 16 on the NSW North Coast have now had their first dose of a COVID-19 vaccine, and 36% have had their second dose. (Figures as of September 6).

The Mid North Coast area is 5% higher than the national average, with 69% of people having had their first dose.

The number of first dose recipients is highest in the Port Macquarie-Hastings local government area, registering in the 70-80% band, followed by Tweed, Bellingen, Ballina, Nambucca, Kempsey, Coffs Harbour, Clarence Valley and Kyogle LGAs are in the 60–70% band.

In the LGAs of Byron, Lismore and Richmond Valley, 50–60% of residents have received their first vaccine dose. We expect this to rise with the increased supply of the Pfizer vaccine starting from next week.

Overall rates in our region have been increasing about 4 to 5% a week, which is on par with national vaccination trends.

Pfizer vaccine supply

Pfizer vaccine supplies are set to significantly increase from mid-September onwards, with an initial doubling of general practice doses from 10,000 to more than 20,000 a week expected.

An additional 70 general practices across the North Coast will offer the Pfizer vaccine from mid-September. This will take the total number of participating practices offering Pfizer to more than 110, as well as the region’s six Commonwealth Vaccination Clinics.

Local Pfizer vaccine supplies will be tripled by October to more than 30,000 doses per week. AstraZeneca vaccines, recommended for those aged 60-plus, are still readily available.

Vaccine Eligibility Checker

Many more North Coast sites will become visible on the Vaccine Eligibility Checker over the coming two weeks as general practices receive their Pfizer deliveries and offer more vaccination time slots.

Healthy North Coast continues to encourage anyone seeking a COVID-19 vaccination to use the eligibility checker to make an appointment, even it that appointment is still several weeks away.

Chief Executive Officer Julie Sturgess said demand for the Pfizer vaccine would remain high, as from Monday, September 13, children aged 12–15 join those eligible to receive the Pfizer jab.